How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Waterproof Orthotics Market
- By Material Type: EVA (Ethylene Vinyl Acetate), Polyurethane, Cork, Gel, Silicone
- By Product Type: Custom Orthotics, Prefabricated Orthotics, Semi-Custom Orthotics
- By Application: Sports and Athletics, Medical and Therapeutic, Everyday Use, Occupational Use
- By End User: Podiatry Clinics, Hospitals and Rehabilitation Centers, Sports Professionals, Retail Consumers
- By Foot Condition: Plantar Fasciitis, Flat Feet (Pes Planus), High Arches (Pes Cavus), Diabetic Foot Ulcers, Arthritis
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - EVA (Ethylene Vinyl Acetate) leads By Material Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Waterproof Orthotics Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Material Type 5
Product Type 3
Application 4
End User 4
Foot Condition 5
Companies profiled
Dr. Scholl's (Bayer AG)
Superfeet Worldwide Inc.
Spenco Medical Corporation
Vionic Group LLC
Sof Sole
Powerstep
OrthoFeet
Pedag International GmbH
Birkenstock Orthopedics
FootBalance Systems Ltd.
Protalus
Currex GmbH
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Dr. Scholl's (Bayer AG)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Superfeet Worldwide Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Spenco Medical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Vionic Group LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sof Sole
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Powerstep
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →OrthoFeet
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Pedag International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Birkenstock Orthopedics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →FootBalance Systems Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Protalus
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Currex GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Aetrex Worldwide Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Tread Labs
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →WalkFit Orthotics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,062M by 2033 · 6.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- EVA (Ethylene Vinyl Acetate)38.5
- Polyurethane18.2
- Cork8.9
- Gel18.4
- Silicone16.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,016M → $1,495M · 4.9%
Europe$708.4M → $1,205M · 6.9%
Asia Pacific$646.8M → $1,017M · 5.8%
Latin America$400.4M → $617.9M · 5.6%
Middle East and Africa$308.0M → $515.6M · 6.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.352026
6.382027
6.382028
6.402029
6.412030
6.422031
6.432032
6.432033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Dr. Scholl's (Bayer AG)11.9
- Superfeet Worldwide Inc.19.5
- Spenco Medical Corporation10.8
- Vionic Group LLC7.3
- Sof Sole10.3
- Powerstep12.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Material Type26.8%
Product Type19.4%
Application15.6%
End User11.9%
Foot Condition26.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.8
- Europe24.9
- Asia Pacific21.0
- Latin America12.7
- Middle East and Africa10.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Dr. Scholl's (Bayer AG) | 79 | 80 | 80 | 80 | 84 | 89 | 82 |
| Superfeet Worldwide Inc. | 91 | 91 | 79 | 83 | 91 | 91 | 88 |
| Spenco Medical Corporation | 71 | 71 | 72 | 76 | 81 | 81 | 75 |
| Vionic Group LLC | 81 | 77 | 77 | 81 | 82 | 74 | 79 |
| Sof Sole | 65 | 53 | 53 | 62 | 62 | 62 | 60 |
| Powerstep | 68 | 69 | 50 | 56 | 57 | 57 | 60 |
| OrthoFeet | 52 | 52 | 49 | 45 | 48 | 55 | 50 |
| Pedag International GmbH | 50 | 50 | 54 | 55 | 55 | 59 | 54 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Dr. Scholl's (Bayer AG)
- Superfeet Worldwide Inc.
- Spenco Medical Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Dr. Scholl's (Bayer AG) | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Superfeet Worldwide Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Spenco Medical Corporation | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Vionic Group LLC | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Sof Sole | − | − | − | ◐ | ◐ | ◐ |
| Powerstep | ◐ | ◐ | ◐ | ◐ | − | − |
| OrthoFeet | − | − | − | − | − | ◐ |
| Pedag International GmbH | ◐ | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Superfeet Worldwide Inc.88
2Dr. Scholl's (Bayer AG)82
3Vionic Group LLC79
4Spenco Medical Corporation75
5Sof Sole60
6Powerstep60
7Pedag International GmbH54
8OrthoFeet50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Dr. Scholl's (Bayer AG)Superfeet Worldwide Inc.Vionic Group LLC
Challenger1
Strong scale, closing on the leaders.
Spenco Medical Corporation
Contender2
Focused players with pockets of strength.
Sof SolePowerstep
Niche2
Specialists in a single segment or region.
OrthoFeetPedag International GmbH
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material Type in North America, then scale across Waterproof Orthotics Market — a $292M beachhead inside a $3.96B market.
Beachhead (SOM)$292Mobtainable near-term
Serviceable (SAM)$1.58Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
EVA (Ethylene Vinyl Acetate)
Best fit — highest urgency & budget in Material Type.
Economic buyer79 fit
Polyurethane
Strong fit — clear ROI and a fast path to value.
End user65 fit
Cork
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel30%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Material Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Waterproof Orthotics Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified20%
Evaluation13%
Closed-won6%
$8.3KCAC
$46KLTV
5.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Waterproof Orthotics Market is a durable-growth opportunity — $8.49B by 2033, compounding at 6.5%.
TAM · 2025$5.12Btoday
TAM · 2033$8.49Bforecast
CAGR6.5%2027–2033
Cumulative$60.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.49BTotal addressable market
SAM$3.52BServiceable available market
SOM$651MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.5% CAGR
Demand compounds through 2033, outpacing GDP across Material Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.49BLarge & growingTAM by 2033 at 6.5% CAGR
$3.52BServiceable nowreachable with today’s model
$651MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.62BBear4.2% CAGR
$8.49BBase6.5% CAGR
$10.9BBull8.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Waterproof Orthotics Market — a $1.42B market by 2033. Plan: grow share from 8.6% to 14.5%.
Market size · 2033$1.42Btotal addressable
Market CAGR6.4%2027–2033
Target share14.5%from 8.6% today
Revenue ambition$206Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.6% | 14.5% | On track |
| Revenue | $120M | $206M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.9% | 38.7% | Ahead |
| Customer retention | 84.9% | 94.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Type capability
A defensible second engine — invest in Product Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $22M capacity & capability investment
- Greenlight bolt-on M&A in Product Type
- Authorise North America expansion plan
- Fund R&D program for Material Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Waterproof Orthotics Market conversation — a $11.7B market you can size, segment and defend in minutes.
Market size · 2033$11.7Btotal opportunity
Growth9.7%CAGR to 2033
Addressable buyers1,513+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material Type
Goal Grow share in Material Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 3 mopayback period
$73K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Dr. Scholl's (Bayer AG)Superfeet Worldwide Inc.Spenco Medical CorporationVionic Group LLCSof SolePowerstepOrthoFeetPedag International GmbH+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Waterproof Orthotics Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Waterproof Orthotics Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Amines Pharmaceutical Solvent Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportCardiovascular Stent Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportInfant Fever Sticker Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportNewborn Screening Equipment Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportCentral Venous Line Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportSurgical Fibrin Formulation Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportBreast-shaped Tissue Expanders Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportInfusion Warmer Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportHypothermia Cap Market
Market size, share, segmentation and regional forecast.
$395M market · 2025 base year
View reportChemotherapy Infusion Set Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportEMG Monitoring System Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportIntervertebral Disc Microsurgical Instruments Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.